During tissue development, stem and progenitor cells are faced with fate decisions coordinated by microenvironmental cues. Although insights have been gained from in vitro and in vivo studies, the role of the microenvironment remains poorly understood due to the inability to systematically explore combinations of stimuli at a large scale. To overcome such restrictions, we implemented an extracellular matrix (ECM) array platform that facilitates the study of 741 distinct combinations of 38 different ECM components in a systematic, unbiased and high-throughput manner. Using embryonic stem cells as a model system, we derived definitive endoderm progenitors and applied them to the array platform to study the influence of ECM, including the interactions of ECM with growth factor signaling, on the specification of definitive endoderm cells towards the liver and pancreas fates. We identified ECM combinations that influence endoderm fate decisions towards these lineages, and demonstrated the utility of this platform for studying ECM-mediated modifications to signal activation during liver specification. In particular, defined combinations of fibronectin and laminin isoforms, as well as combinations of distinct collagen subtypes, were shown to influence SMAD pathway activation and the degree of hepatic differentiation. Overall, our systematic high-throughput approach suggests that ECM components of the microenvironment have modulatory effects on endoderm differentiation, including effects on lineage fate choice and cell adhesion and survival during the differentiation process. This platform represents a robust tool for analyzing effects of ECM composition towards the continued improvement of stem cell differentiation protocols and further elucidation of tissue development processes.
a b s t r a c t
During tissue development, stem and progenitor cells are faced with fate decisions coordinated by microenvironmental cues. Although insights have been gained from in vitro and in vivo studies, the role of the microenvironment remains poorly understood due to the inability to systematically explore combinations of stimuli at a large scale. To overcome such restrictions, we implemented an extracellular matrix (ECM) array platform that facilitates the study of 741 distinct combinations of 38 different ECM components in a systematic, unbiased and high-throughput manner. Using embryonic stem cells as a model system, we derived definitive endoderm progenitors and applied them to the array platform to study the influence of ECM, including the interactions of ECM with growth factor signaling, on the specification of definitive endoderm cells towards the liver and pancreas fates. We identified ECM combinations that influence endoderm fate decisions towards these lineages, and demonstrated the utility of this platform for studying ECM-mediated modifications to signal activation during liver specification. In particular, defined combinations of fibronectin and laminin isoforms, as well as combinations of distinct collagen subtypes, were shown to influence SMAD pathway activation and the degree of hepatic differentiation. Overall, our systematic high-throughput approach suggests that ECM components of the microenvironment have modulatory effects on endoderm differentiation, including effects on lineage fate choice and cell adhesion and survival during the differentiation process. This platform represents a robust tool for analyzing effects of ECM composition towards the continued improvement of stem cell differentiation protocols and further elucidation of tissue development processes.
Statement of Significance
Cellular microarrays can provide the capability to perform high-throughput investigations into the role of microenvironmental signals in a variety of cell functions. This study demonstrates the utility of a highthroughput cellular microarray approach for analyzing the effects of extracellular matrix (ECM) in liver and pancreas differentiation of endoderm progenitor cells. Despite an appreciation that ECM is likely involved in these processes, the influence of ECM, particularly combinations of matrix proteins, had not been systematically explored. In addition to the identification of relevant ECM compositions, this study illustrates the capability of the cellular microarray platform to be integrated with a diverse range of cell fate measurements, which could be broadly applied towards the investigation of cell fate regulation in other tissue development and disease contexts.
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Introduction
To harness the potential of stem and progenitor cells for cell replacement therapies as well as drug discovery and disease modeling platforms, a more complete understanding of the role of microenvironmental signals in cell fate specification is required. Efforts at the interface of bioengineering and cell biology have sought to develop improved culture models which recapitulate in vivo microenvironments in order to study cell differentiation and tissue development. These approaches have emphasized the reduction of multicomponent cellular microenvironments into distinct individual signals that can be tightly controlled in engineering environments, and have provided insights into regulatory mechanisms. However, the understanding of how combinations of microenvironmental cues act together to regulate stem cell fates has been restricted by the iterative nature of these methods. Cellular microarrays can facilitate the combination of distinct biochemical cues in a high-throughput manner, and the quantitative assessment of how such combinatorial microenvironments regulate cell fate decisions. Cellular microarray platforms have been employed to study neural stem cell fate [1] , and towards the clarification of the role of the microenvironment in the mammary gland [2] . Anderson and co-workers used this approach to identify synthetic materials that maintain human embryonic stem cell pluripotency [3] . We have previously developed an extracellular matrix (ECM) microarray, which has been applied towards the examination of hepatocyte survival and stem cell differentiation [4] . Recently, we expanded the throughput of this platform towards the study of lung adenocarcinoma cell adhesion and potential mechanisms underlying metastasis [5] . Here, we have employed an ECM microarray-based approach towards the systematic analysis of liver and pancreas differentiation of endoderm progenitor cells within distinct ECM microenvironments.
In vivo, ventral foregut endoderm is differentially patterned to form liver and pancreas by signals from adjacent mesodermal tissues. In particular, liver specification has been demonstrated to require cooperative signaling induced by fibroblast growth factors (FGFs) secreted by cardiac mesoderm and bone morphogenetic protein (BMP)-4 secreted by the septum transversum mesenchyme [6] [7] [8] . In contrast, ventral endoderm cells which are spatially separated from these signals initiate pancreatic differentiation. Pancreatic fate, revealed by studies in chick and zebrafish, is a result of retinoic acid (RA) [9] , BMP [10] and hedgehog [11, 12] signaling. FGF10 was also shown to be important in the maintenance of Pdx1-positive pancreatic cells in vivo [13, 14] . Together with growth factor signaling, epigenetic changes have additionally been demonstrated to be critical for directing the fate of endoderm cells, for example, increased methylation of distinct promoter regions has been identified to be necessary for hepatic (liver)-lineage commitment [15] . Notably, limited studies have examined the expression of ECM components during liver [16, 17] and pancreas [18] development, or during the in vitro differentiation of stem and progenitor cells [19] [20] [21] . Thus, the role of ECM in the differentiation of hepatic and pancreatic lineages remains primarily unclear.
In this report, we demonstrate an unbiased high-throughput approach for identifying ECM combinations that modulate liver and pancreas differentiation and for investigating the signaling events underlying cell lineage commitment. In particular, we illustrate the scope of this approach by employing multiple iterations of an ECM microarray platform consisting of 741 unique pairwise combinations of 38 ECM molecules, as well as subsequent arrays formulated from focused subsets of ECM combinations for defined mechanistic studies. Overall, our studies highlight the capabilities of a high-throughput cell microarray platform for deconstructing the complex signals regulating endoderm differentiation.
Materials and methods

ECM array fabrication and cell seeding
Vantage acrylic slides (CEL-1 Associates VACR-25C) were coated with polyacrylamide gel pads (60 Â 22 mm) as described previously [22] . ECM domains were arrayed using a DNA Microarray spotter (Cartesian Technologies Pixsys Microarray Spotter and ArrayIt 946 Pins) from 384-well V-bottom source plates containing the ECM combinations previously prepared using a Tecan EVO 150 liquid handler. Specifically, 10 ll volumes of ECM combinations were prepared in the 384-well source plate using the liquid handler, and these ECM combinations were prepared to a final concentration of 200 lg/ml in a previously described buffer [4] , consisting of 100 mM acetate, 5 mM EDTA, 20% glycerol, 0.25% Triton X-100, and pH adjusted to 5.0. 741 combinations were spotted in replicates of five and rhodamine dextran (Invitrogen) was arrayed to dually serve as a negative control for cell adhesion and as an alignment reference for imaging analysis. ECM arrays were stored in a humidified chamber at 4°C, until later use. The following ECM molecules were incorporated into the 741 combination array: Collagen I, Collagen II, Collagen III, Collagen IV, Fibronectin, Laminin, Chondroitin Sulfate, Merosin (Millipore), Collagen V, Collagen VI (BD Biosciences), Aggrecan, Elastin, Keratin, Mucin, Heparan Sulfate, Superfibronectin, Fibrin, Hyaluronan (Sigma), Tenascin-R, F-Spondin, Nidogen-2, Biglycan, Decorin, Galectin 1, Galectin 3, Galectin 4, Galectin 8, Thrombospondin-4, Osteopontin, Osteonectin, Testican 1, Testican 2, Tenascin-C, Nidogen-1, Vitronectin, Rat, Agrin, Brevican (R&D Systems) and Galectin 3c (EMD Biosciences).
Prior to cell seeding, slides containing arrayed ECM domains were washed in PBS and treated with UV light to reduce potential contamination. Slides were placed in a specialized seeding device that holds the top surface of the slides flush with the bottom of the well. Three million cells were seeded on each slide in 5 mL of media and incubated for 12 h at 37°C. After cell attachment, slides were transferred to quadriperm plates (NUNC, 167063), and fresh media was added. For differentiation experiments, arrays containing adherent cells were cultured for 72 h in defined soluble induction conditions (described below) and medium with induction factors was changed daily.
Microarray immunostaining and analysis
At various time points of differentiation induction, slides were washed (three times with PBS) and fixed with 4% paraformaldehyde. Slides were then treated with 0.1% Triton-X in PBS, which also contained Hoechst (Invitrogen) for labeling cell nuclei. Following an additional wash with PBS, slides were stored for 1 h in a blocking solution containing the animal serum corresponding to the secondary antibody. Slides were then incubated with primary antibodies against AFP and Pdx1 (Millipore) overnight at 4°C. Secondary antibody (Invitrogen) incubation for 45 min followed after PBS washes. Slides were finally washed and mounted with Fluoromount-G (Southern Biotech) and stored at 4°C until imaging. The entire slide was imaged using a Nikon Ti-Eclipse inverted fluorescence microscope and NIS Elements Software (Nikon). Image processing and analysis was performed in MATLAB (Mathworks) and nuclei and marker intensity quantification using CellProfiler [23] . Replicate spots (P5 per slide) on each slide were averaged and those whose values were greater than one standard deviation above or below the mean of the replicates were excluded. Slides were normalized to the mean of their non-zero adhesion (cell nuclei #) or protein immunostaining values, to allow for comparison across independent experiments.
mESC culture and differentiation
Sox17/GFP reporter mouse embryonic stem cells [24, 25] were maintained in a feeder dependent culture on mitotically inactivated (Mitomycin C) mouse embryonic fibroblast in media (DMEM F12 medium supplemented with 15% knockout serum replacement, non-essential amino acids, glutamine, penicillin/streptomycin) supplemented with LIF (Millipore). For differentiation towards endoderm, cells were trypsinized and plated on gelatin (sigma) coated 10 cm culture plates and cultured for 7 days in low serum differentiation medium, which consisted of Advanced RPMI 1640 (Invitrogen) base media supplemented with 2% FBS, and further contained 2 lM IDE-2 (Stemgent). The following conditions were used for hepatic and pancreatic induction within the array: hepatic-low serum differentiation medium plus BMP4 (50 ng/ml R&D Systems) and bFGF (10 ng/ml R&D Systems); pancreatic-low serum differentiation medium plus c-KAAD (0.75 lg/ml EMD Bioscience), FGF10 (50 ng/ml R&D Systems) and retinoic acid (2 lg/ ml Sigma). For off-array hepatic differentiation, cells in 10 cm culture plates following IDE-2 treatment and endoderm differentiation, were further cultured for 3 days in low serum differentiation medium containing 50 ng/ml BMP4 and 10 ng/ml bFGF.
Flow activated cell sorting
Definitive endoderm cells were enriched prior to array seeding using FACS, selecting for cells that were sox17-positive (GFPpositive) and CD26-negative. Briefly, cells were harvested following IDE-2 treatment, dispersed to a single cell population, incubated with rat anti-CD26 (FITC, BD Biosciences) at 4°C for 20 min, washed three times with PBS containing 1% FBS, and then incubated with APClabeled anti-rat secondary antibody. For enrichment of Liv2-positive hepatic cells, cells were sequentially incubated with rat anti-Liv2 (MBL International) and APC-labeled anti-rat secondary antibodies. Cells were collected with a MoFlo cell sorter (Beckman Coulter).
Mouse embryo preparation and immunofluorescent staining
Whole mount immunostaining was performed as described [26, 27] . Rat monoclonal antibody to Merosin (laminin a2) was purchased from Abcam and used at 1:100 dilution. Alexa Fluor secondary antibody was used at 1:500 dilution. Specimens were counterstained with DAPI for visualization of cell nuclei. Whole mount immunostained embryos were fixed in 4% paraformaldehyde, dehydrated in 30% sucrose in PBS and embedded in OCT compound for cryosectioning. Experiments using animals were in compliance with institutional ethical use protocols.
Statistical analyses
Unless otherwise specified, data presented as mean ± S.E.M. A minimum of three independent experiments were performed for each study. Student's t-tests were performed utilizing Minitab software comparing the groups of interest using options denoting a two-tailed, two-sample comparison with unequal variance. Clustering analysis was performed based on Euclidean distances using Spotfire (Tibco) with the hierarchical clustering algorithm. For large-scale array experiments, one-way ANOVA with Tukey's Multiple Comparison Test was used to analyze statistical significance.
Results
Microarray-based analysis of endoderm cell adhesion and differentiation
To investigate cell-ECM interactions during liver and pancreatic commitment, we fabricated microarrays consisting of 4000 individual (150 micrometer) domains ('spots') presenting one of 741 different ECM microenvironments (or non-adhesive and collagen I-only controls) that appear in quintuplicate on a single microscope slide. The total concentration of ECM within each spotted domain was held constant at 200 lg/ml. The composition of the 741 unique spots are the result of all single and pairwise combinations of 38 commercially available ECM molecules (Table 1) , which represent a complex library of environments suitable for the study of the influence of ECM on endoderm cell differentiation.
Following fabrication, we seeded the arrays with definitive endoderm (DE) cells, and adapted our previously established analysis pipeline [5] , to quantify adhered cell numbers, differentiation marker expression, and signaling pathway activity within the unique ECM environments over time (Fig. 1A) . DE cells were obtained through the differentiation and fluorescence activated cell sorting (FACS)-based enrichment of mouse embryonic stem (ES) cells. Specifically, mouse ES cells expressing a GFP reporter for Sox17, an endoderm marker, were cultured for 7 days in the presence of a small molecule inducer of endoderm differentiation, IDE-2 [28] . Prior to seeding the arrays, DE cells were enriched from the mixed population of differentiated cells by FACS, selecting for cells that were positive for Sox17/GFP but that did not express CD26, a known visceral endoderm marker. Approximately 40% of day 7 differentiated cells were Sox17+/CD26À (representative experiment illustrated in Supplemental (Fig. 1B ). This cell density and seeding time were optimized such that near confluent islands of DE cells were obtained on many of the ECM combinations. Specifically, the DE cells were capable of robust adhesion to distinct ECM combinations, as illustrated by the reproducibility between replicate spots in the array (Fig. 1C) . Further, visualization of the average adhesion to each domain, through the staining and quantification of cell nuclei per spot, allowed for the identification of ECM combinations that most effectively support adhesion of DE cells (red squares, Fig. 1D ). Among the conditions that most effectively supported DE cell adhesion, combinations containing either fibronectin or laminin (a1) were highly represented. To assess the initial differentiation status of the seeded DE population shortly after adherence to the ECM array, we evaluated the Table 1 ECM molecules presented in the ECM array. ECM array comprises 4000 addressable features per array that are the result of all single and pairwise combinations of the ECM molecules present in this table to a total of 741 unique ECM environments that are represented in quintuplicate plus positive (Collagen I) and negative (dextran, no ECM) controls. expression of DE markers Sox17 and Foxa2 by immunofluorescence (Supplemental Fig. 2 ). Twelve hours post-seeding, cells adherent on the ECM array maintained expression of Sox17 and Foxa2 (Supplemental Fig. 2B-C) . Thus, for subsequent experiments investigating the effects of ECM on liver and pancreas specification, the 12 h post-seeding time point represents day 0 of the array differentiation protocols.
Assessment of ECM adhesion profiles upon induction of hepatic and pancreatic differentiation of endoderm
Hepatic and pancreatic specification of DE cells is regulated in vivo by adjacent tissues that secrete growth and morphogenic factors. By employing the large-scale ECM array, we investigated potential interactions between ECM compositions and known soluble cues that induce hepatic or pancreatic differentiation of endoderm progenitor cells. Following adhesion of DE cells onto the ECM arrays, we treated replicate arrays with hepatic-inducing (+BMP4/ bFGF) or pancreatic-inducing (+RA/c-KAAD/FGF10) soluble conditions for 3 days, and quantified the cell number bound to each ECM domain, based on the intensity of nuclei stain per spot, to generate cell adhesion/survival profiles of the differentiating cells. A comparison of these profiles is illustrated in Fig. 2A , which includes the normalized cell number distributions across the 741 ECM combinations for DE prior to soluble induction (Day 0), as well as following hepatic/pancreatic induction and a noninduced control condition at Day 3. This heat map quantification demonstrates that there are numerous ECM combinations, approximately 180 (24%) conditions, that support the adhesion of mouse DE cells prior to differentiation induction, but lose this supportive capacity during differentiation and/or continued cell culture. In addition, treatment with either hepatic or pancreatic inducing factors leads to distinct adhesion profiles of differentiating cells.
To further explore the kinetic evolution of these distinct profiles, we performed the same experiment, and quantified the adherent cell numbers every 24 h (day 1, day 2, and day 3) after the addition of either hepatic-inducing or pancreatic-inducing soluble factors. At the first time point, the number of adherent cells observed in each differentiation condition align in the x = y axis when plotted relative to each other, indicating no overt ECMmediated selection for or against cell binding or division when in the presence of growth factors that promote either hepatic or pancreatic fate (Fig. 2B ). However, with increased time of exposure to the differentiation conditions, the specific ECM environment to which the cells are adhered appears to influence the bound cell number. Specifically, the number of cells adhered to given ECM combinations aligns more closely with the vertical (pancreatic) or horizontal (hepatic) axis after 48 and 72 h, suggesting that distinct effects of hepatic and pancreatic conditions arise based on ECM context. These results suggest that the differentiation of DE cells may be accompanied by changes in the expression/functionality of adhesion receptors and/or a reduction in pro-survival signals that fail to support differentiating cells in the presence of certain ECM combinations.
In order to explore the possibility that ECM conditions could provide differential survival signals influencing the degree of apoptosis, we performed immunostaining and quantified the levels of activated (cleaved) caspase-3 at multiple time points during differentiation. We observed that the composition of the ECM environment can influence the degree of caspase-3 activation (Supplemental Fig. 3) . Furthermore, these data illustrate that for specific ECM combinations, hepatic and pancreatic inducing conditions can lead to differential activation of caspase-3 (Supplemental Fig. 3 ).
Evaluation of ECM effects on hepatic and pancreatic lineage differentiation
In addition to total bound cell number, we next sought to examine the influence of ECM binding on the degree of differentiation towards hepatic or pancreatic lineages. Within the largescale (741 combinations) ECM microarray, we performed immunostaining to detect the expression of alpha-fetoprotein (AFP), a hepatic lineage marker, and Pdx1, a pancreatic lineage marker, 72 h after hepatic or pancreatic differentiation induction, respectively. We quantified the intensity of signal per spot derived from both cell number (nuclei) and the expression of differentiation markers (AFP or Pdx1) and analyzed the intersection profiles to correlate cell number with degree of differentiation.
Upon hepatic differentiation (Fig. 3A) , we observed a strong correlation between cell number and amount of AFP expression. Specifically, ECM combinations aligned in the x = y axis of the AFP versus nuclei scatter plot, demonstrating that per ECM domain, an elevation in the signal intensity that represents the number of bound cells corresponded with increased AFP expression (Fig. 3A) . The introduction of pancreatic promoting factors resulted in a different profile (Fig. 3B) . In this case, only a subset of ECM combinations demonstrated a positive correlation between cell number and Pdx1 expression, as was observed for the majority of conditions during hepatic differentiation. In contrast, several other combinations aligned closer to the horizontal or the vertical axis, indicating that for pancreatic specification, the role of ECM in supporting cell number is less correlated with the effects of ECM on Pdx1 expression.
To further probe the effects of ECM combinations, we utilized the data from the large-scale array to select 31 ECM conditions of particular interest, and performed differentiation studies using focused arrays containing these ECM compositions (Table 2) . These specific ECM conditions included any combination of two ECM proteins which exhibited a statistically significant effect on hepatic or pancreatic differentiation (Fig. 3) , as well as the individual ECM components present within these select combinations. Among the conditions included in this focused array were the combinations fibronectin + merosin, laminin + superfibronectin, and combinations of collagens I, II, and IV (Fig. 4A-C) . Notably, for these conditions, the combination of two distinct molecules yields effects that were distinct from those observed in the presence of the same ECM molecules presented in isolation. For example, fibronectin alone induced moderate differentiation and supported significant adhesion (cell numbers), while the presence of only merosin supported neither differentiation nor an increase in cell number. However, when combined, differentiation based on AFP expression was enhanced (Fig. 4A ). Combining laminin with superfibronectin yields a similar outcome, in that both hepatic differentiation and total cell number were enhanced relative to DE cells cultured in the presence of either ECM in isolation (Fig. 4A) . The analysis of the combinations of CI, CII and CIV also revealed outcomes that would not have been predicted based on the results observed in single-ECM niches. Specifically, none of the individual molecules supported substantial cell numbers, but the combination of CIV with either CI or CII improved the maintenance of cell number (Fig. 4B) . Regarding differentiation induction, AFP expression was promoted by either CII or CIV both alone and in combination, but CI and CIV only supported hepatic differentiation when combined (Fig. 4B) .
Additional results from the focused 31 ECM array studies are illustrated in Supplemental Fig. 4 , which includes the hepatic differentiation data for conditions not highlighted in Fig. 4 , as well as the complete 31 ECM condition panel data for pancreatic (Pdx1 expression) differentiation. Overall, when comparing the ECM conditions that best supported hepatic and pancreatic differentiation, we noted that two combinations (fibronectin + merosin (laminin a2) and laminin (a1) + superfibronectin) are among the most robust domains for both hepatic and pancreatic differentiation. Additionally, other ECM combinations selectively supported hepatic or pancreatic differentiation. For example, hepatic, but not pancreatic, differentiation was robust in the presence of fibronectin + aggrecan, fibronectin + elastin, collagen II + galectin1, or collagen II + biglycan. In contrast, pancreatic differentiation was selectively supported by collagen IV + fibronectin (Supplemental Fig. 4) . We further examined mRNA expression of AFP and Pdx1 genes following either hepatic or pancreatic differentiation within a multiwell plate format, in which well surfaces were treated with the combination of ECM proteins fibronectin and merosin prior to cell seeding (Supplemental Fig. 5 ). These data confirm that the most pronounced AFP and Pdx1 expression levels are observed following hepatic and pancreatic induction, respectively. 
Comparison to standard multi-well plate culture
To confirm that the process of hepatic differentiation that occurred while bound to the arrays was similar to differentiation that takes place in standard multi-well plates, we utilized the 31-combination focused arrays to evaluate whether cells that underwent array differentiation or 'off-array' differentiation exhibited alterations in their ECM adherence profiles. Specifically, we seeded 31 ECM arrays with ES cell-derived DE cells and cultured these arrays in hepatic-promoting conditions for 3 days (as in Fig. 4A-B) . We directly compared the number of adherent cells per ECM condition to the adhesion pattern of Liv2-expressing hepatic cells, which were seeded on the array for 12 h after 3 days of differentiation in standard culture plates and FACS-based enrichment. Notably, the cell number profiles of these independent conditions exhibit a strong correlation, with only a few select conditions exhibiting any difference between D3 arraydifferentiated DE cells and 'off-array' differentiated Liv2 + cells (Fig. 4D) . These results suggest that for the subset of ECM combinations examined here, the array culture format does not significantly influence the profile of ECM-based adhesion.
Examination of merosin expression in vivo
Merosin preparations collectively consist of multiple laminin isoforms sharing the a2 chain, and deficiencies in laminin a2 have been associated with congenital muscular dystrophies [29] . A role for merosin/laminin a2 in the differentiation of endoderm lineage differentiation has not previously been identified. Immunostaining for merosin in day E8.5 mouse embryos demonstrated expression of merosin in the area of the foregut endoderm, as well as in the ventral endoderm and yolk sac (Fig. 5) , suggesting that merosin, together with localized secreted factors and potentially other ECM components may play a role in endoderm differentiation at this stage.
Application of the ECM microarray platform towards systematic analysis of signaling mechanisms
In addition to performing a quantitative assessment of protein expression to track phenotypic differentiation, we also utilized the microarray platform to investigate signaling pathway activation patterns that may underlie the observed ECM effects. We hypothesized that ECM can act as a modulator of signals generated in response to soluble factors, including the activation of SMAD1, SMAD5, and SMAD8 downstream of BMP4 signaling during hepatic differentiation. In addition, previous studies have observed an increase in histone H3 acetylation (K9 and K14) associated with the AFP promoter, and that blocking these modifications impaired development of the liver bud [15] . Thus, we explored the potential of our microarray platform to examine the effects of ECM on these intracellular events associated with hepatic differentiation.
To investigate the effects of ECM composition on SMAD activation, we utilized the 31 combination ECM array, and performed immunostaining of adherent cells to detect phosphorylated (p) SMAD1/5/8 following 48 h of treatment with BMP4 and bFGF (hepatic-inducing conditions, as employed above). Consistent with the observed impact on induction of AFP expression (Fig. 4A) , the intensity of pSMAD1/5/8 expressed by cells bound to the fibronectin + merosin domain was significantly higher compared to cells present on the individual component spots (Fig. 6A and C) . This result suggests that the positive effect of this ECM combination on hepatic lineage differentiation is at least correlated with, and may be mediated by SMAD signaling in response to BMP4 stimulation. In contrast, cells bound to individual laminin and superfibronectin domains exhibited elevated levels of pSMAD1/5/8 relative to the signaling present in cells bound to the combination of these ECM components (Fig. 6A and C) . In addition, hepatic differentiation in the presence of various collagen combinations led to a range of SMAD activation profiles (Fig. 6B) . Specifically, the intensity of pSMAD1/5/8 was elevated in cells on collagen IV-containing domains, either alone or in combination with collagen I or II. In comparison, adhesion to collagen I appeared to have a negative impact on SMAD 1/5/8 phosphorylation.
In addition to the SMAD pathway, we further evaluated overall histone H3 (K9 and K14) acetylation as surrogate readouts of epigenetic regulation within distinct ECM microenvironments. Employing the 31 combination ECM array as above, we performed immunostaining for H3K9ac and H3K14ac prior to and 48 h following induction of hepatic differentiation. Similar to the effects on SMAD activation, combinatorial ECM compositions influenced H3 acetylation (Supplemental Fig. 6 ). In particular, fibronectin + merosin exhibited increased H3K14 acetylation compared to fibronectin or merosin alone, which correlates well with the effects of ECM on SMAD 1/5/8 phosphorylation and the degree of hepatic differentiation as measured by AFP expression. Collectively, these studies demonstrate the utility of the ECM microarray platform for analyzing the effects of ECM binding on signaling pathway activation and epigenetic modifications, and the potential for correlating these observations with differentiation outcomes across a panel of conditions and time points.
Discussion
In order to deconstruct the complex microenvironmental signaling mechanisms that regulate stem and progenitor fate decisions, higher throughput methods that enable the systematic analysis of combinations of signals are needed. Here, we utilized an ECM microarray platform to examine the role of cell-ECM interactions in endoderm differentiation. Previous efforts have utilized ECM microarrays for analyzing adhesion and differentiation within various cellular contexts. Building on these efforts, our studies represent a significant advancement of the ECM microarray approach in several ways. First, previous work incorporating large-scale combinatorial arrays (>740 distinct combinations of ECM proteins) has been focused on short-term readouts of cell function such as cell adhesion [5] . Here, we demonstrate the integration of such large-scale arrays with cell differentiation measurements. We further highlight the modularity of the microarray approach through the subsequent implementation of focused arrays consisting of subsets of combinations identified within the large-scale format. In addition, previous studies utilizing cell microarray systems to investigate cell differentiation have primarily focused on phenotypic markers [4, 30, 31] . In our studies here, we have expanded on this assessment of cell phenotypic markers, and additionally demonstrate the capability of an ECM microarray approach to enable investigations into cell signaling pathways that underlie cell differentiation processes.
Overall, our results illustrate how cell-ECM interactions evolve during endoderm differentiation to the hepatic or pancreatic lineages. One of the compelling results from these experiments is that upon differentiation induction within the array format, the ECM components that support significant adherent cell numbers rapidly change, and distinct profiles are observed following treatment with either hepatic or pancreatic inducing soluble factors. Several mechanisms may be contributing to the changes observed in these evolving profiles, including potential distinct effects of ECM and soluble factor combinations on cell survival, adhesion, and proliferation. By analyzing the activation of caspase-3, our results demonstrate that ECM can influence the degree of apoptosis (Supplemental Fig. 3 ) triggered during differentiation. These data suggest that following differentiation induction, alterations in ECM-derived survival signals occur, which at least partially contributes to the shifts in cell numbers detected within the array domains. It is likely that changes in ECM adhesion receptors, such as integrins, may also lead to direct cell detachment from the twodimensional array surface. Although our findings suggest that the adhesion profiles of hepatic cells differentiated within the array or off-array are highly correlated (Fig. 4D) , adhesion receptor expression analysis during differentiation would provide additional insight. Also, future studies incorporating time-lapse imaging, as well as the direct assessment of cell proliferation (e.g. quantification of BrDU incorporation) would aid the further decoupling of the effects of ECM on differentiating cell survival, adhesion, and proliferation.
Despite the increasingly recognized importance of ECM within stem and progenitor cell microenvironments [32] , less is known regarding the temporal and spatial dynamics of cell-ECM interactions during the development of endoderm tissues. In lung and intestine, dynamic remodeling of ECM has been demonstrated to be critical in normal tissue development as well as the progression of certain diseases [33] . For liver, distinct developmental stages have been shown to exhibit distinct spatial patterns of integrin receptor expression [34] . Based on the evolving cell adhesion profiles we observed in our studies, we have hypothesized that there are dynamic alterations in the responses of cells to different ECM combinations during endoderm differentiation. Such alterations are consistent with findings in many developmental contexts in which response networks in cells change rapidly after a step in differentiation. For example, for pancreatic specification of endoderm, it has previously been demonstrated that BMP signaling is initially inhibitory, but then becomes an induction stimulus at a later developmental stage [35] . Towards the optimization of stem cell differentiation, it may be beneficial to tailor ECM substrates independently for each stage of differentiation, or alternatively identify a single ECM combination that could support many sequential stages. Thus, building on our results demonstrated here, we anticipate that high-throughput approaches, such as the ECM microarray platform, would enable the systematic assessment of cell-ECM dynamics and support the optimization of directed differentiation protocols.
ECM effects on the degree of differentiation were determined via the expression of hepatic (AFP) and pancreatic (Pdx1) markers in the array 3 days after induction (Fig. 3) . Interestingly, differentiation towards the hepatic fate appears to be closely correlated with cell number (Fig. 3A) . For pancreatic fate, the relationship is more complex, as the data illustrate that some ECM compositions support significant cell numbers and Pdx1 expression, while others exclusively support either increased relative Pdx1 expression or cell number (Fig. 3B) . In comparing the ECM combinations that optimally support hepatic or pancreatic differentiation, a select few appear to support both lineages. In particular, the following two combinations consisting of forms of fibronectin and laminin exhibit this dually-supportive effect: fibronectin + merosin (laminin a2), and superfibronectin + laminin a1. Superfibronectin, which is a multimeric form of fibronectin, generally exhibits enhanced cell adhesive properties [36] , and the effects of this molecule on hepatic and pancreatic differentiation have not previously been reported. Previous work analyzing fibronectin expression in mouse embryos has demonstrated that fibronectin is nonuniformly distributed during endoderm differentiation, and that a reduction in fibronectin content is involved in the development of the foregut region [37] , which is the precursor region for liver and ventral pancreas. In addition, studies utilizing both mouse ES-derived cells and an in vivo zebrafish model, have suggested that fibronectin production by endoderm cells is critical for the differentiation of adjacent mesoderm [38] . Collectively, these in vivo findings together with our array results suggest that future studies systematically exploring the differential effects of fibronectin, including various forms such as superfibronectin, at more highly refined stages of endoderm differentiation are required.
In addition to the identification of the fibronectin and merosin condition, one of the most unexpected results from these experiments was the presence of collagen II in a number of combinations that supported hepatic differentiation, as collagen II is most commonly associated with cartilage differentiation [39] . Future experiments will be required to explore the potential physiologic relevance of collagen II effects on endoderm differentiation, however, several studies have identified collagen II expression in embryonic epithelial tissues [40] [41] [42] . Furthermore, in subsequent investigations it will be important to expand the analyses of ECM effects to include phenotypic markers for alternative lineages derived from endoderm not explored here, such as lung and thyroid. Together with the assessment of hepatic and pancreatic markers at the single cell level, such analyses of alternative lineages would provide additional information regarding the specificity of ECM conditions for directing distinct fates.
We further utilized the ECM microarray platform to investigate the activation of signaling pathways that may participate in the mechanisms of ECM-mediated modulation of hepatic lineage differentiation. Our results demonstrate differential SMAD1/5/8 signaling activation in different ECM compositions, which is suggestive of a potential synergistic interaction between ECM and BMP4, and warrants future investigation. Cooperation between ECM components and BMP4 has been previously been reported in the context of biliary differentiation of hepatoblasts within the developing liver [43] . In addition to SMAD signaling activation, we also explored potential effects of ECM on overall H3 histone acetylation. Future efforts will be aimed at analyzing the acetylation of histones associated with specific loci, such as the AFP promoter, towards determining the potential effects of ECM on these individual genes. Notably, the in vivo deletion of SMAD4, which cooperates with SMAD1/5/8 in BMP signaling, results in the loss of the acetyltransferase P300 at liver gene elements and a decrease in H3 acetylation [15] . Consequently, future efforts using scaled-up versions of the relevant ECM conditions identified here could be applied towards the examination of ECM composition as a potential modifying signal at the intersection of BMP signaling and epigenetic modifications such as histone acetylation.
In addition to mechanistic studies into ECM signaling effects, we anticipate that both the ECM microarray approach and findings reported here could aid in facilitating several processes related to cell sourcing and regenerative medicine applications. First, the identification of ECM conditions that most effectively support cell adhesion at distinct stages of differentiation could mitigate the common difficulties of enriching and replating cells after the initiation of the differentiation processes. Specifically, at each stage, the ECM microarray platform could be applied towards the systematic optimization of cell adhesion while additionally tailoring the differentiation towards downstream lineages. Interestingly, one of the ECM combinations highlighted in our results, fibronectin + merosin, exhibited the capacity to support DE cell adhesion, as well as supported both hepatic and pancreatic differentiation when cultured in corresponding hepatic and pancreatic induction mediums. Treatment of cell culture substrates with fibronectin + merosin, or similar ECM conditions, could serve a very practical purpose of generating robust endoderm cell adhesion for scaled-up liver or pancreas differentiation protocols, or also could be utilized as a substrate for future studies investigating combinatorial soluble or genetic factors regulating the liver and pancreas fate switch.
Conclusions
This report describes the systematic assessment of cell-ECM interactions during DE specification through the implementation of an ECM microarray approach that enables unbiased and highthroughput analysis. Large-scale arrays were complemented with smaller focused arrays consisting of subsets of relevant combinatorial ECM conditions. Utilizing this strategy, we demonstrate that ECM composition can influence differentiation trajectory, and for liver specification, ECM plays a modulatory role in signaling pathway activation and epigenetic alterations associated with effective differentiation. Overall, our studies highlight the capabilities of this platform for examining cell-ECM effects at a scale that more closely represents the complexity of ECM compositions in vivo. Consequently, this approach could be applied towards the study of cell fate decisions and signaling mechanisms within a broad number of tissue development and stem cell differentiation contexts.
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